COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,655 Articles (22,913 medRxiv, 8,742 bioRxiv)

Most recent first Previous |  Page 1943: Articles 19421-19430  | Next

A national retrospective cohort study of mechanical ventilator availability and its association with mortality risk in intensive care patients with COVID-19
Wilde, H. A., Mellan, T. A., Hawryluk, I., Dennis, J., Denaxas, S., Pagel, C., Duncan, A., Bhatt, S., Flaxman, S., Mateen, B. A., Vollmer, S.
10.1101/2021.01.11.21249461 — Posted: 2021-01-13 Discussion: Offsite
Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection
Ahava, M. J., Kurkela, S., Kuivanen, S., Lappalainen, M., Jarva, H., Jaaskelainen, A. J.
10.1101/2021.01.08.20248771 — Posted: 2021-01-13
Model-based cellular kinetic analysis of SARS-CoV-2 infection: different immune response modes and treatment strategies
Zhou, Z., Zhao, Z., Shi, S., Wu, J., Li, D., Li, J., Zhang, J., Gui, K., Zhang, Y., Mei, H., Hu, Y., Ouyang, Q., Li, F.
10.1101/2021.01.11.21249562 — Posted: 2021-01-13
The Relationship between Democracy embracement and COVID-19 reported casualties worldwide
Hussein, M. R., AlSulaiman, T., Habib, M. F., Awad, E. A., Morsi, I., Herbold, J. R.
10.1101/2021.01.11.21249549 — Posted: 2021-01-13
Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients
Sasson, J. M., Campo, J. J., Carpenter, R. M., Young, M. K., Randall, A. Z., Trappl-Kimmons, K., Oberai, A., Hung, C., Edgar, J., Teng, A. A., Pablo, J. V., Liang, X., Yee, A., Petri, W. A., Camerini, D.
10.1101/2021.01.12.21249702 — Posted: 2021-01-13
Impact of COVID-19 pandemic on use of Pediatric Emergency Health Services in a Tertiary Care Pediatric Hospital in North India
Sodani, R., Gupta, S., Kumar, V.
10.1101/2021.01.09.21249489 — Posted: 2021-01-12
Inhibitor Binding Modulates Protonation States in the Active Site of SARS-CoV-2 Main Protease
Kneller, D. W., Phillips, G., Weiss, K. L., Zhang, Q., Coates, L., Kovalevsky, A.
10.1101/2021.01.12.426388 — Posted: 2021-01-12 Discussion: Onsite
Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation.
Garcia, M. A., Barreras, P. V., Lewis, A., Pinilla, G., Sokoll, L. J., Kickler, T., Mostafa, H., Caturegli, M., Moghekar, A., Fitzgerald, K. C., Hopkins Neuro-COVID-19 Group, , Pardo, C. A.
10.1101/2021.01.10.20249014 — Posted: 2021-01-12
Novel RT-ddPCR assays for determining the transcriptional profile of SARS-CoV-2
Telwatte, S., Kumar, N., Vallejo-Gracia, A., Kumar, G. R., Lu, C. M., Ott, M., Wong, J. K., Yukl, S. A.
10.1101/2021.01.12.425991 — Posted: 2021-01-12
Snake venom phospholipases A2 possess a strong virucidal activity against SARS-CoV-2 in vitro and block the cell fusion mediated by spike glycoprotein interaction with the ACE2 receptor
Siniavin, A. E., Nikiforova, M. A., Grinkina, S. D., Gushchin, V. A., Starkov, V. G., Osipov, A. V., Tsetlin, V. I., Utkin, Y. N.
10.1101/2021.01.12.426042 — Posted: 2021-01-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).